UK markets closed

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.65+0.02 (+0.30%)
At close: 04:00PM EST
6.67 +0.02 (+0.30%)
After hours: 07:43PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 628.86M
Enterprise value 767.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)89.64
Price/book (mrq)3.96
Enterprise value/revenue 149.31
Enterprise value/EBITDA -1.76

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-6.86%
S&P500 52-week change 3-7.75%
52-week high 38.58
52-week low 32.87
50-day moving average 37.27
200-day moving average 35.74

Share statistics

Avg vol (3-month) 33.79M
Avg vol (10-day) 33.52M
Shares outstanding 5102.92M
Implied shares outstanding 6N/A
Float 877.24M
% held by insiders 10.90%
% held by institutions 165.69%
Shares short (12 Jan 2023) 418.45M
Short ratio (12 Jan 2023) 45.59
Short % of float (12 Jan 2023) 429.74%
Short % of shares outstanding (12 Jan 2023) 422.25%
Shares short (prior month 14 Dec 2022) 418.45M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21544:1000
Last split date 304 Nov 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-8,526.23%

Management effectiveness

Return on assets (ttm)-29.46%
Return on equity (ttm)-83.77%

Income statement

Revenue (ttm)5.14M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)-93.00%
Gross profit (ttm)-351.14M
EBITDA -446.38M
Net income avi to common (ttm)-431.14M
Diluted EPS (ttm)-10.43
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)139.63M
Total cash per share (mrq)1.68
Total debt (mrq)278.21M
Total debt/equity (mrq)175.13
Current ratio (mrq)1.27
Book value per share (mrq)1.92

Cash flow statement

Operating cash flow (ttm)-436.4M
Levered free cash flow (ttm)-358.89M